05.22.23 -- Practical, Innovative Solutions For AAV Development & Manufacturing

Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real time.

Executives from Moderna, Sanofi Pasteur, Takeda, and Catalent shared behind-the-scenes information on their respective efforts to develop a COVID-19 vaccine. Learn more about the different approaches the companies all adopted as part of a collaborative mindset to arrive at a vaccine as quickly and safely as possible.

Due to its modularity, the SMARTag conjugation platform can be broadly applied to various disease contexts. It leverages ease of analytics and a critical combination of efficacy and tolerability.

What are the current challenges and future promises of adeno-associated virus, lentivirus, and lipid nanoparticles in gene therapies? Explore case studies for AAV technology and manufacturing and strategies for navigating the regulatory environments in the U.S. and Europe.